Is LeMaitre Vascular, Inc. a good dividend stock?

LeMaitre Vascular, Inc. (LMAT) is a dividend-paying stock with a current dividend yield of 0.88%. Review its dividend history, payout consistency and growth to judge whether it fits your income strategy.

What is LMAT's dividend yield?

The dividend yield for LMAT stock is currently 0.88%.

How much does LMAT pay in dividends per year?

LeMaitre Vascular, Inc. pays an annual dividend of $0.9000 per share over the trailing twelve months.

How often does LMAT pay dividends?

LMAT stock pays dividends quarterly.

Is LMAT's dividend growing?

LeMaitre Vascular, Inc.'s 3-year dividend CAGR is 19.3%.

LMAT Stock Price, Chart, Stats & News

LeMaitre Vascular, Inc.

Save

Overview Dividend safety Dividends Fundamentals

LeMaitre Vascular, Inc. (LMAT) is a dividend-paying stock with a current dividend yield of 0.88% as of Jul 10, 2026. It pays $0.9000 per share over the trailing twelve months and distributes quarterly. Its dividend has grown at a 17.03% 5-year compound annual rate.

2.35B

Market cap

39.82x

Current P/E

34.25x

Forward P/E

0.88%

Dividend yield

$0.9000

LMAT dividend

Dividend safety

Strong

Dividend coverage looks healthy — LMAT pays out about 35% of earnings.

See the safety analysis

LMAT chart

Loading chart...

Fundamentals

Gross margin	71.53%
Operating margin	27.21%
Pretax margin	30.12%
Net margin	23.13%
Effective tax rate	23.21%
ROA	9.38%
ROE	15.58%
D/E	0.47x
Interest coverage ratio	13.10x

All financials

LMAT valuation

P/E	39.82x
P/S	9.73x
P/B	6.15x
P/CF	29.80x
P/FCF	32.61x
P/OCF	29.80x
PEG	5.23x
EV multiple	25.02x

About

Health care

Sector

Medical - Instruments & Supplies

Industry

Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins; occlusion catheters that temporarily halt blood flow; perfusion catheters for infusing blood and other fluids into the vasculature; and thrombectomy catheters, featuring a silicone balloon for extracting venous thrombi. The company also furnishes carotid shunts, designed to temporarily redirect blood flow to the brain during carotid endarterectomy surgery to clear arterial plaque.